Keywords: news, brief, aeterna, begin, phase, iii, trial

News In Brief

Article | 20 January 1997

- AEterna is to begin a Phase III trial of Neovastat, previouslycode-named AE-941, in patients with solid tumor cancers refractory to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in